story

Akribion Therapeutics

A new class of cancer therapies using RNA-guided nucleases for specific cell depletion

Biotech, Germany


About Akribion Therapeutics

Akribion Therapeutics is creating a special technology that uses RNA to program the removal of certain cells. Their G-dase E treatment can destroy cells by breaking apart their DNA and RNA, but only if the guide RNA matches a specific RNA sequence inside the cell. This ensures only the targeted cells are affected, while healthy cells stay safe.

Legal Name

: Akribion Therapeutics

Headquarters

: , Germany

Business Model

:

Founding Date

: 1970

No. of Employees

:

Founding Members

Recently Added Startups